YUTIQ J Code: J7314

Drug & Product Overview

HCPCS Descriptor Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg

HCPCS Added Date October 1, 2019

Manufacturer ANI Pharmaceuticals, Inc

Route of Administration Intraocular, Intravitreal

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Implant

About YUTIQ

Yutiq is a medication aligned to the HCPCS J Code: J7314 for billing, pricing, and reimbursement purposes in the United States. This Ophthalmology medication is administered via the intraocular or intravitreal routes and manufactured by ANI Pharmaceuticals, Inc.

According to CMS Drug Use Information: Drug uses not available

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

2 NDC packages are crosswalked to J7314. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	YUTIQ
	YUTIQ

Login to view 2 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

YUTIQ Pricing & Reimbursement

J7314 Private Payer Reimbursement

$531.16 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

YUTIQ CPT Administration Codes

CPT Code	Description
67027	Implantation of intravitreal drug delivery system, includes concomitant removal of vitreous

JW / JZ modifiers apply

CMS has identified Yutiq (J7314) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

YUTIQ Medically Unlikely Edits (MUE)

The most billing units of J7314 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.01 mg.

Practitioner Office & Hospital Outpatient

36 units / day

= 0.36 mg per day

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

YUTIQ Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

chronic non-infectious uveitis affecting the posterior segment of the eye

Drug Class

Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]

Frequently Asked Questions

Is there an available Yutiq billing and coding guide?

Our team has not identified a manufacturer-published source of billing and coding information for YUTIQ.

Are there any available Yutiq patient assistance programs?

Our team has not identified a manufacturer-published source of patient assistance information for YUTIQ.

Where can I find Yutiq prescribing information?

YUTIQ prescribing information can be found at the link below: Visit Here →

Where can I find Yutiq side effect information?

Our team has not yet identified a source of side effects information for YUTIQ. Please check back in a few weeks.

Does billing YUTIQ require JZ/JW wastage modifiers?

CMS has identified YUTIQ(J7314) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.